Quarterly report pursuant to Section 13 or 15(d)

NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)

v3.19.1
NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Jan. 01, 2019
NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]        
Research and Development Expense $ 1,488,839 $ 862,420 $ 862,420  
Cash, Uninsured Amount $ 10,683,593   $ 4,200,160  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares) 3,940,828   3,135,828  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number (in Shares) 3,042,512   3,007,946  
Amortization of Intangible Assets $ 2,726      
Operating Lease, Liability, Current 158,836     $ 419,000
Operating Lease, Right-of-Use Asset $ 380,586   $ 0 $ 418,838
Patents [Member]        
NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]        
Finite-Lived Intangible Asset, Useful Life 10 years